Immunogenicity and Safety of Biological E’s Monovalent rDNA Hepatitis B Vaccine (BEVAC®) in Neonates and Infants: A Multicentre, Randomized, Phase IV Non-Inferiority Trial

Authors

Institutions

Publication Details

Journal
Viruses
Published
2026-04-17
DOI
https://doi.org/10.3390/v18040472
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and Safety of Biological E’s Monovalent rDNA Hepatitis B Vaccine (BEVAC®) in Neonates and Infants: A Multicentre, Randomized, Phase IV Non-Inferiority Trial

Pradeep Nanjappa, SubbaReddy Gunneri, Subhash Thuluva, Rammohan Reddy Mogulla et al.
Viruses
Hepatitis B Virus Studies
article

Immunogenicity and Safety of Biological E’s Monovalent rDNA Hepatitis B Vaccine (BEVAC®) in Neonates and Infants: A Multicentre, Randomized, Phase IV Non-Inferiority Trial

Pradeep Nanjappa, SubbaReddy Gunneri, Subhash Thuluva, Rammohan Reddy Mogulla, Chirag Dhar, Vijay Yerroju, Kamal Thammireddy, Niranjana Mahantshetti, Raju Esanakarra, Siddalingaiah Ningaiah
article en

Abstract

No abstract available for this paper.
VirusesVol. 18(4)
Biological E (India) (IN), Mysore Medical College (IN), KLE Society Hospital (IN)
Good health and well-being
Openalex Percentile: Top 20%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.